GB0722650D0 - Novel imaging method - Google Patents

Novel imaging method

Info

Publication number
GB0722650D0
GB0722650D0 GBGB0722650.9A GB0722650A GB0722650D0 GB 0722650 D0 GB0722650 D0 GB 0722650D0 GB 0722650 A GB0722650 A GB 0722650A GB 0722650 D0 GB0722650 D0 GB 0722650D0
Authority
GB
United Kingdom
Prior art keywords
imaging method
novel imaging
novel
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0722650.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB0722650.9A priority Critical patent/GB0722650D0/en
Publication of GB0722650D0 publication Critical patent/GB0722650D0/en
Priority to JP2010534461A priority patent/JP5709522B2/ja
Priority to US12/742,984 priority patent/US8834843B2/en
Priority to PCT/EP2008/065824 priority patent/WO2009071444A2/en
Priority to CN200880117542.XA priority patent/CN101951964B/zh
Priority to BRPI0820430-6A priority patent/BRPI0820430A2/pt
Priority to EP08856281A priority patent/EP2219681A2/en
Priority to RU2010119187/15A priority patent/RU2505316C2/ru
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0722650.9A 2007-11-19 2007-11-19 Novel imaging method Ceased GB0722650D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0722650.9A GB0722650D0 (en) 2007-11-19 2007-11-19 Novel imaging method
JP2010534461A JP5709522B2 (ja) 2007-11-19 2008-11-19 新規イメージング法
US12/742,984 US8834843B2 (en) 2007-11-19 2008-11-19 Imaging method
PCT/EP2008/065824 WO2009071444A2 (en) 2007-11-19 2008-11-19 Novel imaging method
CN200880117542.XA CN101951964B (zh) 2007-11-19 2008-11-19 成像方法
BRPI0820430-6A BRPI0820430A2 (pt) 2007-11-19 2008-11-19 Composto
EP08856281A EP2219681A2 (en) 2007-11-19 2008-11-19 Imaging method
RU2010119187/15A RU2505316C2 (ru) 2007-11-19 2008-11-19 Способ визуализации

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0722650.9A GB0722650D0 (en) 2007-11-19 2007-11-19 Novel imaging method

Publications (1)

Publication Number Publication Date
GB0722650D0 true GB0722650D0 (en) 2007-12-27

Family

ID=38896533

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0722650.9A Ceased GB0722650D0 (en) 2007-11-19 2007-11-19 Novel imaging method

Country Status (8)

Country Link
US (1) US8834843B2 (https=)
EP (1) EP2219681A2 (https=)
JP (1) JP5709522B2 (https=)
CN (1) CN101951964B (https=)
BR (1) BRPI0820430A2 (https=)
GB (1) GB0722650D0 (https=)
RU (1) RU2505316C2 (https=)
WO (1) WO2009071444A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2571486C1 (ru) * 2014-11-05 2015-12-20 Общество с ограниченной ответственностью "ДИАМЕД" Способ визуализации воспалений
EP3967704A4 (en) * 2019-06-11 2022-08-31 FUJIFILM Corporation CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATOR MATERIAL AND CULTURE MEDIUM

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents
ATE399542T1 (de) * 2003-10-01 2008-07-15 Merck Patent Gmbh Alfavbeta3 und alfavbeta6 integrin antagonisten als antifibrotische mittel
DE602005025911D1 (de) * 2004-11-22 2011-02-24 Ge Healthcare As Kontrastmittel für eine extrazelluläre matrix
EP1833512A1 (en) 2005-01-06 2007-09-19 GE Healthcare AS Optical imaging
WO2006115416A2 (en) 2005-04-25 2006-11-02 Ge Healthcare As Liposomes
CA2663749A1 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
GB0524987D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
WO2007148074A1 (en) 2006-06-21 2007-12-27 Hammersmith Imanet Limited Chemical methods and apparatus

Also Published As

Publication number Publication date
CN101951964B (zh) 2013-05-29
CN101951964A (zh) 2011-01-19
JP2011506273A (ja) 2011-03-03
WO2009071444A9 (en) 2009-10-01
WO2009071444A2 (en) 2009-06-11
US20100316565A1 (en) 2010-12-16
EP2219681A2 (en) 2010-08-25
US8834843B2 (en) 2014-09-16
WO2009071444A3 (en) 2009-12-23
BRPI0820430A2 (pt) 2015-05-26
RU2010119187A (ru) 2011-12-27
RU2505316C2 (ru) 2014-01-27
JP5709522B2 (ja) 2015-04-30

Similar Documents

Publication Publication Date Title
EP2191318A4 (en) IMAGING APPARATUS
GB0712395D0 (en) Method
GB0713896D0 (en) Method
GB0707096D0 (en) Method
GB0812938D0 (en) Novel method
EP2171169A4 (en) METHOD
GB0721202D0 (en) Novel method
EP2069862A4 (en) IMAGING APPARATUS
GB0701076D0 (en) Imaging apparatus
GB0708567D0 (en) Imaging technique
GB0703366D0 (en) Method
GB2449558B (en) Imaging apparatus
GB0710174D0 (en) Imaging apparatus
GB0818738D0 (en) Imaging neuroflammation
GB0717365D0 (en) Imaging
GB0710321D0 (en) Method
GB0708960D0 (en) Method
GB0714338D0 (en) method
GB0711843D0 (en) Method
GB0705321D0 (en) Method
GB0714239D0 (en) Method
GB0710520D0 (en) Method
GB0710519D0 (en) Method
GB0722650D0 (en) Novel imaging method
GB0714135D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)